SCHEMBL19904503

SCHEMBL19904503

O=C(NC(Cc1ccc2c(c1)OCCO2)CN1CCCC1)C1CCN(c2ccc(Cl)c(OC3CC3)c2)C1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACACB O00763 8/20 0.40
PDCD1 Q15116 2/20 0.39
CD274 Q9NZQ7 2/20 0.39
ALDH1A1 P00352 2/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 1/20 0.39
NOTUM Q6P988 3/20 0.36
HTR1A P08908 1/20 0.36
UGCG Q16739 1/20 0.35
SSTR3 P32745 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904516 0.94 ACACB (0.40) ACACBPDCD1CD274ALDH1A1USP2
SCHEMBL19904464 0.91 NOTUM (0.45) ACACBPDCD1CD274ALDH1A1USP2
SCHEMBL19904425 0.91 NOTUM (0.45) ACACBPDCD1CD274ALDH1A1USP2
SCHEMBL19904571 0.88 PDCD1 (0.36) ACACBPDCD1CD274ALDH1A1USP2
SCHEMBL19904519 0.88 SMN1; SMN2 (0.41) ACACBPDCD1CD274ALDH1A1USP2
SCHEMBL18101713 0.88 KMT2A (0.49) ACACBPDCD1CD274ALDH1A1USP2
SCHEMBL19904451 0.88 KMT2A (0.49) ACACBPDCD1CD274ALDH1A1USP2
SCHEMBL18101714 0.88 KMT2A (0.49) ACACBPDCD1CD274ALDH1A1USP2
SCHEMBL18101715 0.88 KMT2A (0.49) ACACBPDCD1CD274ALDH1A1USP2
SCHEMBL19904652 0.88 KMT2A (0.49) ACACBPDCD1CD274ALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed